A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2020 Dec 15;S1569-1993(20)30906-1. doi: 10.1016/j.jcf.2020.11.003.
Document
Link
Keywords
Clinical trial [4]
Ivacaftor [6]
Tezacaftor [7]
Date
Tuesday, December 15, 2020
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [8]